Publications by authors named "Philipp Riedler"
Neurobiol Dis
February 2020
Article Synopsis
- Recent evidence indicates that brain degeneration may lead to the formation of inflammatory lesions in Multiple Sclerosis (MS).
- A pre-clinical study using mice showed that treating with Laquinimod during induced brain degeneration (from cuprizone) significantly reduced inflammation and immune cell recruitment compared to untreated mice.
- The findings suggest that addressing primary brain degeneration could prevent the secondary immune response and inflammatory damage, impacting how clinical MS treatments are understood.
